Pella Pharmaceuticals Co. Is A Jordanian Pharmaceutical Manufacturer Established In 2009, Focusing On Dermatological And Cosmetic Products. The Company Began Production In 2011 And Has Since Built A Reputation For Innovation And Quality In Skincare Solutions. With An Estimated Revenue Between $11M And $100M, Pella Employs Between 51 And 200 People And Is Led By Ceo Bashar Tawfiq Atwan Bataineh.Pella'S Core Offerings Include Generic Dermatological Pharmaceuticals, Such As Therapeutic Topical Treatments, And Cosmetic Products Like Anti-Aging Creams And Acne Solutions Under The Derma Pella Brand. The Company Also Engages In Contract Manufacturing, Partnering With Other Businesses For Third-Party Production. Pella Exports Its Products To Countries Like India, Sri Lanka, And Turkey, While Sourcing Raw Materials From Suppliers In India And Turkey. The Company Aims To Lead In Generic Dermatological Manufacturing And Promote Skin Health Awareness, Targeting Medical Communities, Distributors, And Consumers.
